Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device

Daniel B. Sims, Gregg Rosner, Nir Uriel, José González-Costello, Frederick A. Ehlert, Ulrich P. Jorde

Research output: Contribution to journalArticle

25 Scopus citations

Abstract

Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous-flow LVADs have become the preferred LVAD technology. As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation. (PACE 2012; 35:e144-e148)

Original languageEnglish (US)
Pages (from-to)e144-e148
JournalPACE - Pacing and Clinical Electrophysiology
Volume35
Issue number5
DOIs
StatePublished - May 1 2012
Externally publishedYes

Keywords

  • chronic heart failure
  • left ventricular assist device
  • ventricular fibrillation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device'. Together they form a unique fingerprint.

  • Cite this